Continuous Glucose Monitoring to Assess Glycemia in Chronic Kidney Disease - Changing Glucose Management

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
The goal of this study is to test whether a dipeptidyl peptidase-4 inhibitor, compared with a sulfonylurea, improves time in normal blood glucose range and reduces blood glucose variability. Blood glucose is measured using a continuous glucose monitoring device.
Epistemonikos ID: 7919aedf4e3244b0881d5de8fb484099a9b96092
First added on: May 12, 2024